Market Research Logo

Global Antifungal Agents Market Forecast 2018-2026

Global Antifungal Agents Market Forecast 2018-2026

KEY FINDINGS

The global antifungal agents market is chiefly being propelled by factors like poor hygiene habits, supportive policies and programs by government and the development of drug resistance. By the end of the forecast period of 2018-2026, the market is likely to register a CAGR of 3.72%.

MARKET INSIGHTS

The antifungal agents market is segmented on the basis of drug types, therapeutic indications, types, applications, and geography. The antifungal agents market on the basis of drug types is segmented into systemic azoles, topical azoles, systemic polyenes, topical polyenes, systemic echinocandins, systemic antimetabolites, other systemic, other topical and other drugs types. On the basis of therapeutic indications, the market includes aspergillosis market, dermatophytosis, candidiasis and others. Market by type includes prescription and over the counter drugs.The antifungal agents market by application is segregated into topical antifungal drugs and oral drugs. The antifungal drugs market on the basis of geography is segmented into Asia-Pacific, Europe, Rest of the World and North America.

REGIONAL INSIGHTS

North America antifungal drugs market possessed a colossal market share of the global antifungal agents market in 2017. A large number of people suffering from fungal infection and advancement in antifungal biopharmaceuticals in the region is upsurging the growth of the antifungal market. On the other hand, the Asia-Pacific region is projected to be the fastest-growing region for the global antifungal agents market. The Europe antifungal drugs market is also estimated to grow at a healthy CAGR during the forecast period.

COMPETITIVE INSIGHTS

The leading market players in the global antifungal agents market are Abbott Laboratories, Strategic Initiatives, Arbor Pharmaceuticals, Inc, Baxter, Astellas Pharma Inc, Bayer Healthcare, Teva Pharmaceuticals, Gilead, GlaxoSmithKline, Johnson & Johnson, Kramer Laboratories, Merck & Co, Novartis, Pfizer, Sanofi-Aventis, and Vertex Pharmaceuticals.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
2.5. Estimation Methodology
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Tropical Drugs Market Is The Emerging Application
3.2.2. Aspergillosis Therapeutic Indication Is Leading The Market
4. Market Determinants
4.1. Market Drivers
4.1.1. Poor Hygiene Habits
4.1.2. Development Of Drug Resistance
4.1.3. Healthcare Policies And Programs By Government
4.2. Market Restraints
4.2.1. Growing Aging Population In Some Regions
4.2.2. Alternate Treatment Options
4.2.3. Regulatory Atmosphere
4.3. Market Opportunities
4.3.1. Emerging Pipeline Of New And Innovative Antifungal Drugs
4.3.2. Healthcare And Related Industries Are Growing Continuously
4.3.3. Increasing Awareness And Availability Of Information
4.4. Market Challenges
4.4.1. Growth And Development Of The Generic Antifungal Drugs Market
4.4.2. Side Effects And Recurring Fungal Infections
4.4.3. Resistance To Drugs
4.4.4. Rapidly Changing Technology
5. Market Segmentation
5.1. Market By Drug Types 2018-2026
5.1.1. Systemic Azoles
5.1.2. Topical Azoles
5.1.3. Systemic Polyenes
5.1.4. Topical Polyenes
5.1.5. Systemic Echinocandins
5.1.6. Systemic Antimetabolics
5.1.7. Other Systemic
5.1.8. Other Topical
5.1.9. Other Drugs Types
5.2. Market By Therapeutic Indications 2018-2026
5.2.1. Aspergillosis Market
5.2.2. Dermatophytosis Market
5.2.3. Candidiasis Market
5.2.4. Other Therapeutic Indication Market
5.3. Market By Applications 2018-2026
5.3.1. Topical Antifungal Agents Market
5.3.2. Oral Drugs Market
5.4. Market By Types 2018-2026
5.4.1. Prescription
5.4.2. Over The Counter (Otc)
6. Key Analytics
6.1. Porter’s Five Force Model
6.1.1. Threat Of New Entrants
6.1.2. Threat Of Substitute Products Or Services
6.1.3. Bargaining Power Of Buyer
6.1.4. Bargaining Power Of Supplier
6.1.5. Intensity Of Competitive Rivalry
6.2. Key Buying Criteria
6.3. Value Chain Analysis
6.3.1. Manufacturers
6.3.2. Distributors
6.3.3. Retailers
6.3.4. End-users
6.4. Strategic Recommendation
6.5. Strategic Conclusions
6.6. Regulatory Framework
6.6.1. Regulation In North America
6.6.2. Regulation In Europe
6.6.3. Regulation In Asia Pacific
6.6.4. Regulation In Latin America
6.6.5. Regulation In Middle East And Africa
6.7. Opportunity Matrix
7. Geographical Analysis
7.1. North America
7.1.1. The United States (U.S.)
7.1.2. Canada
7.2. Europe
7.2.1. United Kingdom (Uk)
7.2.2. France
7.2.3. Germany
7.2.4. Spain
7.2.5. Italy
7.2.6. Benelux
7.2.7. Scandinavia
7.2.8. Austria
7.2.9. Rest Of Europe
7.3. Asia Pacific
7.3.1. India
7.3.2. China
7.3.3. Japan
7.3.4. South Korea
7.3.5. Taiwan
7.3.6. Rest Of Apac
7.4. Rest Of World
7.4.1. Latin America
7.4.1.1. Brazil
7.4.1.2. Mexico
7.4.1.3. Argentina
7.4.1.4. Chile
7.4.1.5. Rest Of Latin America
7.4.2. Middle East And Africa (Mea)
8. Company Profiles
8.1. Competitive Landscape
8.1.1. Market Share Analysis
8.2. Abbott Laboratories.
8.2.1. Company Overview
8.2.2. Product Portfolio
8.2.3. Scot Analysis
8.2.4. Strategic Initiatives
8.3. Arbor Pharmaceuticals, Inc.
8.3.1. Company Overview
8.3.2. Product Portfolio
8.3.3. Scot Analysis
8.3.4. Strategic Initiatives
8.4. Baxter
8.4.1. Company Overview
8.4.2. Product Portfolio
8.4.3. Scot Analysis
8.4.4. Strategic Initiatives
8.5. Astellas Pharma Inc.
8.5.1. Company Overview
8.5.2. Product Portfolio
8.5.3. Scot Analysis
8.5.4. Strategic Initiatives
8.6. Bayer Healthcare
8.6.1. Company Overview
8.6.2. Product Portfolio
8.6.3. Scot Analysis
8.6.4. Strategic Initiative
8.7. Teva Pharmaceuticals
8.7.1. Company Overview
8.7.2. Product Portfolio
8.7.3. Scot Analysis
8.7.4. Strategic Initiatives
8.8. Gilead
8.8.1. Company Overview
8.8.2. Product Portfolio
8.8.3. Scot Analysis
8.8.4. Strategic Initiatives
8.9. Glaxosmithkline
8.9.1. Company Overview
8.9.2. Portfolio
8.9.3. Scot Analysis
8.9.4. Strategic Initiatives
8.10. Johnson & Johnson
8.10.1. Company Overview
8.10.2. Product Portfolio
8.10.3. Scot Analysis
8.10.4. Strategic Initiatives
8.11. Kramer Laboratories
8.11.1. Company Overview
8.11.2. Product Portfolio
8.11.3. Scot Analysis
8.12. Merck & Co.
8.12.1. Company Overview
8.12.2. Portfolio
8.12.3. Scot Analysis
8.12.4. Strategic Initiatives
8.13. Novartis
8.13.1. Company Overview
8.13.2. Product Portfolio
8.13.3. Scot Analysis
8.13.4. Strategic Initiatives
8.14. Pfizer
8.14.1. Company Overview
8.14.2. Product Portfolio
8.14.3. Scot Analysis
8.14.4. Strategic Initiatives
8.15. Sanofi-aventis
8.15.1. Company Overview
8.15.2. Product Portfolio
8.15.3. Scot Analysis
8.15.4. Strategic Initiative
8.16. Vertex Pharmaceuticals
8.16.1. Company Overview
8.16.2. Product Portfolio
8.16.3. Scot Analysis
8.16.4. Strategic Initiative
Table List
Table 1 Global Antifungal Agents Market By Geography 2018-2026 ($million)
Table 2 Skin Lesions Occurring Due To Antifungal Infection
Table 3 Indian Government Initiatives In Healthcare Sector
Table 4 Global Antifungal Agents Market By Drug Types Market 2018-2026 ($ Million)
Table 5 Drug Uses Of Triazoles
Table 6 Global Antifungal Agents Market In Systemic Azoles By Geography 2018-2026 ($ Million)
Table 7 Global Antifungal Agents Market In Topical Azoles By Geography 2018-2026 ($ Million)
Table 8 Global Antifungal Agents Market In Systemic Polyenes By Geography 2018-2026 ($ Million)
Table 9 Global Antifungal Agents Market In Topical Polyenes By Geography 2018-2026 ($ Million)
Table 10 Indication And Doses Of Echinocandin By Us Approved Drug Usage
Table 11 Global Antifungal Agents Market In Systemic Echinocandins By Geography 2018-2026 ($ Million)
Table 12 Global Antifungal Agents Market In Systemic Antimetabolics By Geography 2018-2026 ($ Million)
Table 13 Global Antifungal Agents Market In Other Systemic By Geography 2018-2026 ($ Million)
Table 14 Global Antifungal Agents Market In Other Topical By Geography 2018-2026 ($ Million)
Table 15 Global Antifungal Agents Market In Other Drugs Types Market By Geography 2018-2026 ($ Million)
Table 16 Global Antifungal Agents Market By Therapeutic Indications Market 2018-2026 ($ Million)
Table 17 Global Antifungal Agents Market In Aspergillosis By Geography 2018-2026 ($ Million)
Table 18 Symptoms In The Affected Area Caused By Dermatophytes
Table 19 Global Antifungal Agents Market In Dermatophytosis Market By Geography 2018-2026 ($ Million)
Table 20 Symptoms In The Affected Area Caused By Candidiasis
Table 21 Global Antifungal Agents Market In Candidiasis By Geography 2018-2026 ($ Million)
Table 22 Global Antifungal Agents Market In Other Therapeutic Indication By Geography 2018-2026 ($ Million)
Table 23 Global Antifungal Agents Market By Applications Market 2018-2026 ($ Million)
Table 24 Pros And Cons Of Topical Medications
Table 25 Antifungal Powders And It’s Effect
Table 26 Antifungal Ointment And It’s Effect
Table 27 Antifungal Pastes And It’s Effect
Table 28 Global Antifungal Agents Market In Topical Antifungal Agents By Geography 2018-2026 ($ Million)
Table 29 Commonly Used Antifungal Drugs Dosage And It’s Effects
Table 30 Global Antifungal Agents Market In Oral Drugs By Geography 2018-2026 ($ Million)
Table 31 Global Antifungal Agents Market By Types 2018-2026 ($ Million)
Table 32 Global Antifungal Agents Market In Prescription By Geography 2018-2026 ($ Million)
Table 33 Global Antifungal Agents Market In Otc By Geography 2018-2026 ($ Million)
Table 34 Global Anti-fungal Agent Market By Geography 2018-2026 ($ Million)
Table 35 North America Anti-fungal Market By Countries 2018-2026 ($ Million)
Table 36 Europe Antifungal Agents Market By Countries 2018-2026( $ Million)
Table 37 Total Burden Of Fungal Infections In Spain 2016
Table 38 Asia Pacific Antifungal Agents Market By Countries 2018-2026($ Million)
Table 39 India’s Healthcare Sector Investment
Table 40 Companies In China Producing Antifungal Drugs
Table 41 Rest Of World Antifungal Agents Market 2018-2026($ Million)
Table 42 Latin America Antifungal Agents Market By Countries 2018-2026($ Million)
Figures List
Figure 1 Global Antifungal Agents Market 2018-2026 ($million)
Figure 2 Industry In The World Is Rapidly Growing (%)
Figure 3 Topical Antifungal Agents Types
Figure 4 Porter’s Five Force Model In Antifungal Agents Market
Figure 5 Value Chain Of Antidepressant Drugs
Figure 6 The United States Anti-fungal Agents Market 2018-2026 ($ Million)
Figure 7 Canada Antifungal Agent Market 2018-2026 ($ Million)
Figure 8 Final Consumption Of Medical Goods And Services By Household
Figure 9 The United Kingdom Antifungal Agents Market 2018-2026($million)
Figure 10 Investment Made By Different Agents In France 2017(%)
Figure 11 France Anti-fungal Agents Market 2018-2026($ Million)
Figure 12 Germany Anti-fungal Agents Market 2018-2026($ Million)
Figure 13 Spain Anti-fungal Market 2018-2026($ Million)
Figure 14 Italy Anti-fungal Market 2018-2026($ Million)
Figure 15 Benelux Anti-fungal Market 2018-2026($ Million)
Figure 16 Scandinavia Anti-fungal Market 2018-2026($ Million)
Figure 17 Austria Anti-fungal Market 2018-2026($ Million)
Figure 18 Rest Of Europe Anti-fungal Market 2018-2026($ Million)
Figure 19 India Antifungal Agents Market 2018-2026($ Million)
Figure 20 China Antifungal Agents Market 2018-2026($ Million)
Figure 21 Japan Antifungal Agents Market 2018-2026($ Million)
Figure 22 South Korea Antifungal Agents Market 2018-2026($ Million)
Figure 23 Taiwan Antifungal Agents Market 2018-2026($ Million)
Figure 24 Rest Of Apac Antifungal Agents Market 2018-2026($ Million)
Figure 25 Latin America Antifungal Agents Market 2018-2026($ Million)
Figure 26 Brazil Antifungal Agents Market 2018-2026($ Million)
Figure 27 Mexico Antifungal Agents Market 2018-2026($ Million)
Figure 28 Argentina Antifungal Agents Market 2018-2026($ Million)
Figure 29 Chili Antifungal Agents Market 2018-2026($ Million)
Figure 30 Rest Of Latin America Antifungal Agents Market 2018-2026($ Million)
Figure 31 Various Sectors Investments In The Mea Region
Figure 32 Middle East And Africa Antifungal Agents Market 2018-2026($ Million)
Figure 33 Anti-fungal Agent Company Market Share Analysis 2017 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report